REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

Bayesian Capital Management, LP's Holding History (CIK: 0001632551)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 83,500 Value ($000) $433 Avg Close — Range —
Q2 2022
Shares 18,700 Value ($000) $258 Avg Close — Range —
Q1 2022
Shares 14,800 Value ($000) $289 Avg Close — Range —